Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lysine Vasopressin, Phenylalanine
2. Octapressin
3. Octopressin
4. Phelypressin
5. Phenylalanine Lysine Vasopressin
6. Phenylalanyl-lysyl Vasopressin
7. Plv-2
8. Vasopressin, Phenylalanine Lysine
9. Vasopressin, Phenylalanyl Lysyl
10. Vasopressin, Phenylalanyl-lysyl
1. Plv-2
2. 56-59-7
3. Felypressine
4. Felypressinum
5. 2-(l-phenylalanine)-8-l-lysinevasopressin
6. Felipresina
7. Phe(2)-lys(8)-vasopressin
8. Chebi:60564
9. (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide
10. L-cysteinyl-l-phenylalanyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1-6)disulfide
11. 1-{[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-l-prolyl-l-lysylglycinamide
12. Felipresina [inn-spanish]
13. Felypressine [inn-french]
14. Felypressinum [inn-latin]
15. Unii-17n2918v6g
16. Ncgc00182033-01
17. Einecs 200-282-7
18. Vasopressin, 2-l-phenylalanine-8-l-lysine-
19. Dsstox_cid_28525
20. Dsstox_rid_82797
21. Dsstox_gsid_48599
22. Schembl33291
23. Chembl3185126
24. Dtxsid6048599
25. Hy-a0182
26. Tox21_112932
27. 17n2918v6g
28. Cs-5837
29. Db00093
30. Cas-56-59-7
31. L-cysteinyl-l-phenylalanyl-l-phenylalanyl-l-glutaminyl-l-asparaginyl-l-cysteinyl-l-prolyl-l-lysylglycinamide Cyclic (1->6)disulfide
32. H-[cys-phe-phe-gln-asn-cys]-pro-lys-gly-nh2
33. A913370
34. (s)-n-((s)-6-amino-1-((2-amino-2-oxoethyl)amino)-1-oxohexan-2-yl)-1-((4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide
Molecular Weight | 1040.2 g/mol |
---|---|
Molecular Formula | C46H65N13O11S2 |
XLogP3 | -3.5 |
Hydrogen Bond Donor Count | 12 |
Hydrogen Bond Acceptor Count | 15 |
Rotatable Bond Count | 19 |
Exact Mass | 1039.43679229 g/mol |
Monoisotopic Mass | 1039.43679229 g/mol |
Topological Polar Surface Area | 456 Ų |
Heavy Atom Count | 72 |
Formal Charge | 0 |
Complexity | 1920 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For use as an alternative to adrenaline as a localising agent, provided that local ischaemia is not essential.
Felypressin is a synthetic analog of lypressin or vasopressin with a greater vasoconstrictor activity than antidiuretic action. It is used primarily as a hemostatic.
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Felypressin binds to the vasopressin receptor V1a. This causes contraction of the smooth muscle in the vascular bed, especially capillaries, small arterioles and venules.
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?